Zura Bio Limited (ZURA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-70.8%

$1.15

vs $3.94 price

Levered DCF

$1.16

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

10.72

Safe zone

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
P/E	-4.94×	-4.17×	-2.08×	-3.85×	18.1×
P/B	4.86×	1.28×	2.42×	-3.9×	0×
P/S	0×	0×	0×	0×	0×
EV / EBITDA	-5.6×	-0.21×	-0.73×	-4.8×	0×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	0.0%
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%
Current ratio	9.05×	9.16×	4.97×	0.12×	0×
Debt / equity	0×	0×	0×	-0.24×	0×
Interest coverage	0×	0×	0×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Return on equity	-67.6%	-35.7%	-101.7%	80.3%	0.0%
Return on invested capital	-74.1%	-34.5%	-77.8%	1509.0%	0.0%
Return on assets	-60.2%	-29.2%	-59.9%	-489.1%	0.0%
Free cash flow yield	-13.2%	-15.0%	-16.0%	-10.6%	-0.9%
Earnings yield	-13.9%	-27.9%	-42.0%	-20.6%	6.7%
Enterprise value	$384M	$11.2M	$44M	$131.1M	$0
Net debt / EBITDA	1.59×	3.37×	1.65×	-0.23×	0×
Cash conversion cycle (days)	0	0	0	0	0